Andrew Bean
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Neuropeptides and Animal Physiology, interferon and immune responses, Receptor Mechanisms and Signaling, Advanced Bandit Algorithms Research
Most-Cited Works
- → Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study(2022)211 cited
- → Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.(2019)187 cited
- → Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions(1987)54 cited
- → Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.(1989)44 cited
- → Low levels of somatostatin-like immunoreactivity in neocortex resected from presumed seizure foci in epileptic patients(1992)42 cited
- → Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies(2014)39 cited
- → Minimizing pharmacodynamic interactions of high doses of lacosamide(2011)22 cited
- → Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer(2020)18 cited
- → Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions(1991)15 cited
- → Universal Switching and Side Information Portfolios Under Transaction Costs Using Factor Graphs(2012)15 cited